OR WAIT null SECS
September 19, 2019
The new program, Cornerstone, integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of gene therapy medicinal products.
August 21, 2019
Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.
August 12, 2019
The acquisition expands Eurofins Genomics’ gene portfolio while bolstering Blue Heron’s production capabilities.
July 17, 2019
Abcam has acquired the entire live cell line and lysates portfolio of gene-editing therapy developer, EdiGene.
July 03, 2019
Metabolic-disease biotech Amicus Therapeutics announced a manufacturing agreement with Catalent’s Paragon Gene Therapy unit for gene therapy manufacturing.
July 01, 2019
Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.
June 19, 2019
Be The Match BioTherapies and TrakCel have announced a collaboration to provide integrated solutions for companies developing cell and gene therapies.
May 16, 2019
Locate Bio has been granted additional investment to the tune of £2 million (US$2.6 million) for the expansion of its cell and gene therapy pipeline.
May 03, 2019
In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK.
March 29, 2019
NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.